<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36911711</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>1080154</StartPage><MedlinePgn>1080154</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1080154</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1080154</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Immunoglobulin A (IgA) is the main antibody isotype in body fluids such as tears, intestinal mucous, colostrum, and saliva. There are two subtypes of IgA in humans: IgA1, mainly present in blood and mucosal sites, and IgA2, preferentially expressed in mucosal sites like the colon. In clinical practice, immunoglobulins are typically measured in venous or capillary blood; however, alternative samples, including saliva, are now being considered, given their non-invasive and easy collection nature. Several autoimmune diseases have been related to diverse abnormalities in oral mucosal immunity, such as rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus (SLE).</AbstractText><AbstractText Label="METHODS">We decided to evaluate the levels of both IgA subtypes in the saliva of SLE patients. A light chain capture-based ELISA measured specific IgA1 and IgA2 levels in a cohort of SLE patients compared with age and gender-matched healthy volunteers.</AbstractText><AbstractText Label="RESULTS">Surprisingly, our results indicated that in the saliva of SLE patients, total IgA and IgA1 subtype were significantly elevated; we also found that salivary IgA levels, particularly IgA2, positively correlate with anti-dsDNA IgG antibody titers. Strikingly, we also detected the presence of salivary anti-nucleosome IgA antibodies in SLE patients, a feature not previously reported elsewhere.</AbstractText><AbstractText Label="CONCLUSIONS">According to our results and upon necessary validation, IgA characterization in saliva could represent a potentially helpful tool in the clinical care of SLE patients with the advantage of being a more straightforward, faster, and safer method than manipulating blood samples.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Romero-Ram&#xed;rez, Sosa-Hern&#xe1;ndez, Cervantes-D&#xed;az, Carrillo-V&#xe1;zquez, Meza-S&#xe1;nchez, N&#xfa;&#xf1;ez-&#xc1;lvarez, Torres-Ruiz, G&#xf3;mez-Mart&#xed;n and Maravillas-Montero.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero-Ram&#xed;rez</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Red de Apoyo a la Investigaci&#xf3;n, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico e Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sosa-Hern&#xe1;ndez</LastName><ForeName>V&#xed;ctor A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Red de Apoyo a la Investigaci&#xf3;n, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico e Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Biomedicina Molecular, Centro de Investigaci&#xf3;n y de Estudios Avanzados del Instituto Polit&#xe9;cnico Nacional, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervantes-D&#xed;az</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Red de Apoyo a la Investigaci&#xf3;n, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico e Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Medicina, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrillo-V&#xe1;zquez</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Departamento de Medicina Interna, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meza-S&#xe1;nchez</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Red de Apoyo a la Investigaci&#xf3;n, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico e Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfa;&#xf1;ez-&#xc1;lvarez</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a y Reumatolog&#xed;a, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Ruiz</LastName><ForeName>Jiram</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a y Reumatolog&#xed;a, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Mart&#xed;n</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departamento de Inmunolog&#xed;a y Reumatolog&#xed;a, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maravillas-Montero</LastName><ForeName>Jos&#xe9; L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Red de Apoyo a la Investigaci&#xf3;n, Universidad Nacional Aut&#xf3;noma de M&#xe9;xico e Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007071">Immunoglobulin A, Secretory</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007071" MajorTopicYN="Y">Immunoglobulin A, Secretory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009061" MajorTopicYN="N">Mouth Mucosa</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IgA</Keyword><Keyword MajorTopicYN="N">IgA1</Keyword><Keyword MajorTopicYN="N">IgA2</Keyword><Keyword MajorTopicYN="N">saliva</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36911711</ArticleId><ArticleId IdType="pmc">PMC9992540</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1080154</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kett K, Brandtzaeg P, Radl J, Haaijman JJ. Different subclass distribution of IgA-producing cells in human lymphoid organs and various secretory tissues. J Immunol (1986) 136(10):3631&#x2013;5. doi: 10.4049/jimmunol.136.10.3631</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.136.10.3631</ArticleId><ArticleId IdType="pubmed">3517160</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaniv G, Twig G, Shor DB, Furer A, Sherer Y, Mozes O, et al. . A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients. Autoimmun Rev (2015) 14(1):75&#x2013;9. doi: 10.1016/j.autrev.2014.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2014.10.003</ArticleId><ArticleId IdType="pubmed">25449682</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkeller-Yusel F, Hulstaart F, Hannet I, Isenberg D, Lydyard P. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus (1993) 2(4):227&#x2013;31. doi: 10.1177/0961203393002001081</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203393002001081</ArticleId><ArticleId IdType="pubmed">8268970</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. . 2019 European League against Rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis (2019) 78(9):1151&#x2013;9. doi: 10.1136/annrheumdis-2018-214819</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-214819</ArticleId><ArticleId IdType="pubmed">31383717</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Baby B, Zhou Y, Wu T. Emerging molecular markers towards potential diagnostic panels for lupus. Front Immunol (2021) 12:808839. doi: 10.3389/fimmu.2021.808839</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.808839</ArticleId><ArticleId IdType="pmc">PMC8792845</ArticleId><ArticleId IdType="pubmed">35095896</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmettler S, Ong MS, Farmer JR, Choi H, Walter J. Association of immunoglobulin levels, infectious risk, and mortality with rituximab and hypogammaglobulinemia. JAMA Netw Open (2018) 1(7):e184169. doi: 10.1001/jamanetworkopen.2018.4169</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.4169</ArticleId><ArticleId IdType="pmc">PMC6324375</ArticleId><ArticleId IdType="pubmed">30646343</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, et al. . Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol (2017) 139(3S):S1&#x2013;S46. doi: 10.1016/j.jaci.2016.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.09.023</ArticleId><ArticleId IdType="pubmed">28041678</ArticleId></ArticleIdList></Reference><Reference><Citation>Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dorner T, et al. . Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2011) 70(6):909&#x2013;20. doi: 10.1136/ard.2010.144998</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.144998</ArticleId><ArticleId IdType="pmc">PMC3086093</ArticleId><ArticleId IdType="pubmed">21378402</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukhari M, Abernethy R, Deighton C, Ding T, Hyrich K, Lunt M, et al. . BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. Rheumatol (Oxford) (2011) 50(12):2311&#x2013;3. doi: 10.1093/rheumatology/ker106a</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker106a</ArticleId><ArticleId IdType="pubmed">21546351</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilek DE, Lim N, Ding L, Murray SG, Diamond B, Wofsy D. Correlation of hypogammaglobulinaemia with proteinuria, and the relationship between hypogammaglobulinaemia and infection in active lupus nephritis. Lupus Sci Med (2017) 4(1):e000229. doi: 10.1136/lupus-2017-000229</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2017-000229</ArticleId><ArticleId IdType="pmc">PMC5704742</ArticleId><ArticleId IdType="pubmed">29214037</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. . EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis (2016) 75(9):1583&#x2013;94. doi: 10.1136/annrheumdis-2016-209133</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-209133</ArticleId><ArticleId IdType="pubmed">27338776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong PF, Aslam L, Karim MY, Khamashta MA. Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus. Rheumatol (Oxford) (2008) 47(9):1400&#x2013;5. doi: 10.1093/rheumatology/ken255</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken255</ArticleId><ArticleId IdType="pubmed">18625660</ArticleId></ArticleIdList></Reference><Reference><Citation>Conley ME, Delacroix DL. Intravascular and mucosal immunoglobulin a: two separate but related systems of immune defense? Ann Intern Med (1987) 106(6):892&#x2013;9. doi: 10.7326/0003-4819-106-6-892</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-106-6-892</ArticleId><ArticleId IdType="pubmed">3579073</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagarasan S, Honjo T. Intestinal IgA synthesis: regulation of front-line body defences. Nat Rev Immunol (2003) 3(1):63&#x2013;72. doi: 10.1038/nri982</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri982</ArticleId><ArticleId IdType="pubmed">12511876</ArticleId></ArticleIdList></Reference><Reference><Citation>Woof JM, Mestecky J. Mucosal immunoglobulins. Immunol Rev (2005) 206:64&#x2013;82. doi: 10.1111/j.0105-2896.2005.00290.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00290.x</ArticleId><ArticleId IdType="pubmed">16048542</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandtzaeg P, Johansen FE. Mucosal b cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol Rev (2005) 206:32&#x2013;63. doi: 10.1111/j.0105-2896.2005.00283.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0105-2896.2005.00283.x</ArticleId><ArticleId IdType="pubmed">16048541</ArticleId></ArticleIdList></Reference><Reference><Citation>Delacroix DL, Dive C, Rambaud JC, Vaerman JP. IgA subclasses in various secretions and in serum. Immunology (1982) 47(2):383&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1555453</ArticleId><ArticleId IdType="pubmed">7118169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutteh WH, Prince SJ, Hammond KR, Kutteh CC, Mestecky J. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin Exp Immunol (1996) 104(3):538&#x2013;42. doi: 10.1046/j.1365-2249.1996.36742.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.1996.36742.x</ArticleId><ArticleId IdType="pmc">PMC2200440</ArticleId><ArticleId IdType="pubmed">9099941</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladjeva I, Peterman JH, Mestecky J. IgA subclasses of human colostral antibodies specific for microbial and food antigens. Clin Exp Immunol (1989) 78(1):85&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1534603</ArticleId><ArticleId IdType="pubmed">2478328</ArticleId></ArticleIdList></Reference><Reference><Citation>Mestecky J, Russell MW. IgA subclasses. Monogr Allergy (1986) 19:277&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">3093850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadiafshar A, Mohsenifard MR, Mazloomzadeh S. Evaluation of serum &amp; salivary IgA in patients with type 1 diabetes. PloS One (2015) 10(4):e0122757. doi: 10.1371/journal.pone.0122757</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0122757</ArticleId><ArticleId IdType="pmc">PMC4395210</ArticleId><ArticleId IdType="pubmed">25875365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaleyani P, Sardari F, Akbari M. Salivary IgA and IgG in oral lichen planus and oral lichenoid reactions diseases. Adv BioMed Res (2012) 1:73. doi: 10.4103/2277-9175.102977</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2277-9175.102977</ArticleId><ArticleId IdType="pmc">PMC3544108</ArticleId><ArticleId IdType="pubmed">23326803</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung YH, Lee YH, Chen PP, Lin YZ, Lin CH, Yen JH. Role of salivary immune parameters in patients with primary sjogren&#x2019;s syndrome. Ann Lab Med (2019) 39(1):76&#x2013;80. doi: 10.3343/alm.2019.39.1.76</Citation><ArticleIdList><ArticleId IdType="doi">10.3343/alm.2019.39.1.76</ArticleId><ArticleId IdType="pmc">PMC6143464</ArticleId><ArticleId IdType="pubmed">30215233</ArticleId></ArticleIdList></Reference><Reference><Citation>Patidar KA, Parwani RN, Wanjari SP. Correlation of salivary and serum IgG, IgA levels with total protein in oral submucous fibrosis. J Oral Sci (2011) 53(1):97&#x2013;102. doi: 10.2334/josnusd.53.97</Citation><ArticleIdList><ArticleId IdType="doi">10.2334/josnusd.53.97</ArticleId><ArticleId IdType="pubmed">21467820</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez MM, Pessoa JS, Ciamponi AL, Diniz MB, Santos M, Alves HHO, et al. . Correlation of salivary immunoglobulin a with body mass index and fat percentage in overweight/obese children. J Appl Oral Sci (2018) 27:e20180088. doi: 10.1590/1678-7757-2018-0088</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1678-7757-2018-0088</ArticleId><ArticleId IdType="pmc">PMC6223782</ArticleId><ArticleId IdType="pubmed">30427474</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos Ljungberg K, Borjesson E, Martinsson K, Wettero J, Kastbom A, Svard A. Presence of salivary IgA anti-citrullinated protein antibodies associate with higher disease activity in patients with rheumatoid arthritis. Arthritis Res Ther (2020) 22(1):274. doi: 10.1186/s13075-020-02363-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-020-02363-0</ArticleId><ArticleId IdType="pmc">PMC7681967</ArticleId><ArticleId IdType="pubmed">33225988</ArticleId></ArticleIdList></Reference><Reference><Citation>Trull AK, Panayi GS. Serum and secretory IgA immune response to klebsiella pneumoniae in ankylosing spondylitis. Clin Rheumatol (1983) 2(4):331&#x2013;7. doi: 10.1007/BF02041551</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02041551</ArticleId><ArticleId IdType="pubmed">6430627</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. . Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (2012) 64(8):2677&#x2013;86. doi: 10.1002/art.34473</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Salguero E, Mondragon-Ramirez GK, Alcantara-Montiel JC, Cerbulo-Vazquez A, Villegas-Dominguez X, Contreras-Vargas VM, et al. . Infectious episodes during pregnancy, at particular mucosal sites, increase specific IgA1 or IgA2 subtype levels in human colostrum. Matern Health Neonatol Perinatol. (2019) 5:9. doi: 10.1186/s40748-019-0104-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40748-019-0104-x</ArticleId><ArticleId IdType="pmc">PMC6558797</ArticleId><ArticleId IdType="pubmed">31205733</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandtzaeg P. Secretory immunity with special reference to the oral cavity. J Oral Microbiol (2013) 5:1&#x2013;24. doi: 10.3402/jom.v5i0.20401</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jom.v5i0.20401</ArticleId><ArticleId IdType="pmc">PMC3595421</ArticleId><ArticleId IdType="pubmed">23487566</ArticleId></ArticleIdList></Reference><Reference><Citation>Putterman C, Furie R, Ramsey-Goldman R, Askanase A, Buyon J, Kalunian K, et al. . Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements. Lupus Sci Med (2014) 1(1):e000056. doi: 10.1136/lupus-2014-000056</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000056</ArticleId><ArticleId IdType="pmc">PMC4225732</ArticleId><ArticleId IdType="pubmed">25396070</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunekreef T, Limper M, Melchers R, Mathsson-Alm L, Dias J, Hoefer I, et al. . Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies. Lupus Sci Med (2021) 8(1):e000531. doi: 10.1136/lupus-2021-000531</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000531</ArticleId><ArticleId IdType="pmc">PMC8562534</ArticleId><ArticleId IdType="pubmed">34725184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr MA. The structure and function of human IgA. Biochem J (1990) 271(2):285&#x2013;96. doi: 10.1042/bj2710285</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2710285</ArticleId><ArticleId IdType="pmc">PMC1149552</ArticleId><ArticleId IdType="pubmed">2241915</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva LS, Almeida BL, de Melo AK, de Brito DC, Braz AS, Freire EA. IgA nephropathy in systemic lupus erythematosus patients: case report and literature review. Rev Bras Reumatol Engl Ed (2016) 56(3):270&#x2013;3. doi: 10.1016/j.rbr.2014.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rbr.2014.10.011</ArticleId><ArticleId IdType="pubmed">27267646</ArticleId></ArticleIdList></Reference><Reference><Citation>Peen E, Mellbye OJ, Haga HJ. IgA rheumatoid factor in primary sjogren&#x2019;s syndrome. Scand J Rheumatol (2009) 38(1):46&#x2013;9. doi: 10.1080/03009740802366043</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03009740802366043</ArticleId><ArticleId IdType="pubmed">18942022</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hoovels L, Vander Cruyssen B, Sieghart D, Bonroy C, Nagy E, Pullerits R, et al. . IgA rheumatoid factor in rheumatoid arthritis. Clin Chem Lab Med (2022) 60(10):1617&#x2013;26. doi: 10.1515/cclm-2022-0244</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2022-0244</ArticleId><ArticleId IdType="pubmed">35790193</ArticleId></ArticleIdList></Reference><Reference><Citation>Song DJ, Shen J, Chen MH, Liu ZJ, Cao Q, Hu PJ, et al. . Association of serum immunoglobulins levels with specific disease phenotypes of crohn&#x2019;s disease: A multicenter analysis in China. Front Med (Lausanne) (2021) 8:621337. doi: 10.3389/fmed.2021.621337</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.621337</ArticleId><ArticleId IdType="pmc">PMC8115723</ArticleId><ArticleId IdType="pubmed">33996846</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassidy JT, Kitson RK, Selby CL. Selective IgA deficiency in children and adults with systemic lupus erythematosus. Lupus (2007) 16(8):647&#x2013;50. doi: 10.1177/0961203307077543</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203307077543</ArticleId><ArticleId IdType="pubmed">17711902</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Aryeh H, Gordon N, Szargel R, Toubi E, Laufer D. Whole saliva in systemic lupus erythematosus patients. Oral Surg Oral Med Oral Pathol (1993) 75(6):696&#x2013;9. doi: 10.1016/0030-4220(93)90425-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0030-4220(93)90425-4</ArticleId><ArticleId IdType="pubmed">7685874</ArticleId></ArticleIdList></Reference><Reference><Citation>Male CJ. Immunoglobulin A1 protease production by haemophilus influenzae and streptococcus pneumoniae. Infect Immun (1979) 26(1):254&#x2013;61. doi: 10.1128/iai.26.1.254-261.1979</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.26.1.254-261.1979</ArticleId><ArticleId IdType="pmc">PMC414604</ArticleId><ArticleId IdType="pubmed">40880</ArticleId></ArticleIdList></Reference><Reference><Citation>Janoff EN, Rubins JB, Fasching C, Charboneau D, Rahkola JT, Plaut AG, et al. . Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol (2014) 7(2):249&#x2013;56. doi: 10.1038/mi.2013.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2013.41</ArticleId><ArticleId IdType="pmc">PMC4456019</ArticleId><ArticleId IdType="pubmed">23820749</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S, Yu C, Yu B. Changes of serum IL-6, IL-10 and TNF-alpha levels in patients with systemic lupus erythematosus and their clinical value. Am J Transl Res (2021) 13(4):2867&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129414</ArticleId><ArticleId IdType="pubmed">34017450</ArticleId></ArticleIdList></Reference><Reference><Citation>Godsell J, Rudloff I, Kandane-Rathnayake R, Hoi A, Nold MF, Morand EF, et al. . Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus. Sci Rep (2016) 6:34604. doi: 10.1038/srep34604</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34604</ArticleId><ArticleId IdType="pmc">PMC5052569</ArticleId><ArticleId IdType="pubmed">27708376</ArticleId></ArticleIdList></Reference><Reference><Citation>Facciotti F, Larghi P, Bosotti R, Vasco C, Gagliani N, Cordiglieri C, et al. . Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6(+)B helper T cells in systemic lupus erythematosus. Proc Natl Acad Sci U S A. (2020) 117(13):7305&#x2013;16. doi: 10.1073/pnas.1917834117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1917834117</ArticleId><ArticleId IdType="pmc">PMC7132288</ArticleId><ArticleId IdType="pubmed">32184325</ArticleId></ArticleIdList></Reference><Reference><Citation>Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol (1998) 16(3):283&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9631750</ArticleId></ArticleIdList></Reference><Reference><Citation>He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, et al. . Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity (2007) 26(6):812&#x2013;26. doi: 10.1016/j.immuni.2007.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.04.014</ArticleId><ArticleId IdType="pubmed">17570691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M, Du L, Brandtzaeg P, Pan-Hammarstrom Q. IgA subclass switch recombination in human mucosal and systemic immune compartments. Mucosal Immunol (2014) 7(3):511&#x2013;20. doi: 10.1038/mi.2013.68</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2013.68</ArticleId><ArticleId IdType="pubmed">24064668</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques CP, Victor EC, Franco MM, Fernandes JM, Maor Y, de Andrade MS, et al. . Salivary levels of inflammatory cytokines and their association to periodontal disease in systemic lupus erythematosus patients. A case-control study. Cytokine (2016) 85:165&#x2013;70. doi: 10.1016/j.cyto.2016.06.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2016.06.025</ArticleId><ArticleId IdType="pubmed">27371775</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T, et al. . Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheumatol (2005) 52(4):1129&#x2013;37. doi: 10.1002/art.20980</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20980</ArticleId><ArticleId IdType="pubmed">15818711</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y, Xiao Y, Zeng F, Jiang L, Yan S, Wang X, et al. . Assessment of anti-nucleosome antibody (ANuA) isotypes for the diagnosis and prediction of systemic lupus erythematosus and lupus nephritis activity. Clin Exp Med (2022). doi: 10.1007/s10238-022-00942-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-022-00942-w</ArticleId><ArticleId IdType="pubmed">36385418</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalta D, Bizzaro N, Bassi N, Zen M, Gatto M, Ghirardello A, et al. . Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PloS One (2013) 8(8):e71458. doi: 10.1371/journal.pone.0071458</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0071458</ArticleId><ArticleId IdType="pmc">PMC3741383</ArticleId><ArticleId IdType="pubmed">23951169</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan VD, Patwardhan MM, Ghosh K. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Indian J Dermatol Venereol Leprol. (2010) 76(2):145&#x2013;9. doi: 10.4103/0378-6323.60558</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0378-6323.60558</ArticleId><ArticleId IdType="pubmed">20228543</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Prokopec SD, Morrison S, Lou W, Reich H, Gladman D, et al. . Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus. Rheumatol (Oxford) (2015) 54(3):449&#x2013;57. doi: 10.1093/rheumatology/keu326</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu326</ArticleId><ArticleId IdType="pmc">PMC4334682</ArticleId><ArticleId IdType="pubmed">25193804</ArticleId></ArticleIdList></Reference><Reference><Citation>Marco H, Smith RM, Jones RB, Guerry MJ, Catapano F, Burns S, et al. . The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease. BMC Musculoskelet Disord (2014) 15:178. doi: 10.1186/1471-2474-15-178</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2474-15-178</ArticleId><ArticleId IdType="pmc">PMC4038057</ArticleId><ArticleId IdType="pubmed">24884562</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguiar R, Araujo C, Martins-Coelho G, Isenberg D. Use of rituximab in systemic lupus erythematosus: A single center experience over 14 years. Arthritis Care Res (Hoboken) (2017) 69(2):257&#x2013;62. doi: 10.1002/acr.22921</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22921</ArticleId><ArticleId IdType="pubmed">27110698</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaghlouth I, Johnson SR, Pullenayegum E, Gladman D, Urowitz M. Immunoglobulin levels in systemic lupus erythematosus: A narrative review. Lupus (2021) 30(6):867&#x2013;75. doi: 10.1177/09612033211004714</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211004714</ArticleId><ArticleId IdType="pubmed">33779380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, et al. . B cell depletion therapy in systemic lupus erythematosus: Relationships among serum b lymphocyte stimulator levels, autoantibody profile and clinical response. Ann Rheum Dis (2008) 67(7):1011&#x2013;6. doi: 10.1136/ard.2007.079418</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2007.079418</ArticleId><ArticleId IdType="pubmed">17962238</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijpe J, van Imhoff GW, Vissink A, van der Wal JE, Kluin PM, Spijkervet FK, et al. . Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with sjogren&#x2019;s syndrome and associated MALT lymphoma. Ann Rheum Dis (2005) 64(6):958&#x2013;60. doi: 10.1136/ard.2004.030684</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2004.030684</ArticleId><ArticleId IdType="pmc">PMC1755505</ArticleId><ArticleId IdType="pubmed">15576414</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>